Try a review on the sample project.

Eight findings from a short review article. Filter by AI suggestion, open a finding to see its passage, and make the decisions yourself. Nothing here is saved.

Illustrative sample. Exemplarib, its trials, statements, sources and passages are fictional; in RefPack they come from your manuscript and your reference PDFs.

Review

Approving against the AI, rejecting, or marking a source unavailable asks for a reason, just as it does in RefPack.

Sample project · Exemplarib review8 findings · 6 decided

Statement · manuscript p. 2

More than 80% of patients had clear or almost clear skin at week 52.⁵

Partly supportedAI suggestion · your decision is separate

The source reports 58% to 74%, depending on baseline severity. "More than 80%" overstates it.

reference-05.pdfp. 5 of 11

At week 52 of the extension, between 58% and 74% of patients had clear or almost clear skin, with the highest rates in patients with milder disease at baseline.

Your decision

Statement · manuscript p. 3

No serious infections were reported during long-term treatment.⁶

Not supportedAI suggestion · your decision is separate

The source reports serious infections; the statement says there were none.

reference-06.pdfp. 7 of 8

Over 52 weeks, serious infections were reported in 1.2% of patients, most often respiratory infections.

Your decision · reason: Source reports adverse events

Statement · manuscript p. 4

Response to exemplarib does not depend on body weight.⁸

No passage foundAI suggestion · your decision is separate

No passage about body weight was found in this PDF. Check the source yourself, or select the passage if it is there.

reference-08.pdfp. 1 of 6

Patients took exemplarib 30 mg once daily for 16 weeks, then entered the extension. Responses were assessed at weeks 16 and 52…

Your decision

Illustrative sample. Your decisions here are not saved.

Deliver

When the findings are decided, RefPack builds the reference pack: the annotated manuscript, the annotated source PDFs, the evidence table and a list of exceptions, in one ZIP file.

What's in the pack

Reference packExemplarib review

Cover sheetPDF
Annotated manuscript6 statements
Annotated sources7 PDFs
Evidence table8 rows
Not available1 reference
Exceptions2

reference-02.pdf · annotatedp. 4

Exemplarib in moderate plaque psoriasis: the SAMPLE-1 trial

Adults with moderate plaque psoriasis were randomly assigned to exemplarib or placebo for 16 weeks.

In SAMPLE-1, patients took exemplarib 30 mg by mouth once dailyRef 2 · F-02 for 16 weeks, then continued into the extension period.

Skin scores were assessed every four weeks by investigators who did not know the treatment assignment.

The same three steps with your own manuscript

Prepare. Add your manuscript and reference PDFs; RefPack finds each cited statement and matches its source.
Review. Check each finding with the passage in view, with or without AI search.
Deliver. Create the reference pack from your decisions.

Run the same check on your own manuscript.

Get started free Talk to us about teams

Try a review on the sample project.

Eight findings from a short review article. Filter by AI suggestion, open a finding to see its passage, and make the decisions yourself. Nothing here is saved.

Illustrative sample. Exemplarib, its trials, statements, sources and passages are fictional; in RefPack they come from your manuscript and your reference PDFs.